Mobile Application to Improve Physical Activity in Patients With Heart Failure
NCT07928934, Not applicable, Not yet recruiting, Abant Izzet Baysal University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Mobile Application to Improve Physical Activity in Patients With Heart Failure | ClinicalTrials.gov |
| NCT number | NCT07928934 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 82 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Abant Izzet Baysal University | ClinicalTrials.gov |
| Conditions | Heart Failure, Adherence | ClinicalTrials.gov |
| Interventions | Intervention | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Physical activity behavior | from baseline to 3 months | Physical activity behavior will be assessed using the SIMPAQ, a validated and reliable instrument that evaluates physical activity and sedentary behavior over the previous seven days. The questionnaire consists of five items addressing time spent in bed, sedentary activities, walking, exercise, and incidental daily activities. Moderate-to-vigorous physical activity duration will be calculated by summing the reported walking and exercise durations. Changes in SIMPAQ scores will be evaluated to determine the effect of the mobile application-supported intervention on participants' physical activity behavior. The Turkish version of the SIMPAQ has demonstrated good test-retest reliability, with intraclass correlation coefficients (ICC) ranging from 0.87 to 0.99 across its five items. | ClinicalTrials.gov |
| Secondary | Quality of life | from baseline to 3 months | Health-related quality of life will be assessed using the LVD-36, a disease-specific instrument consisting of 36 true/false items designed to evaluate the impact of heart failure and left ventricular dysfunction on patients' daily lives and well-being. Scores range from 0 to 100, with higher scores indicating poorer quality of life. The Turkish version of the questionnaire has demonstrated acceptable internal consistency, with a Cronbach's alpha coefficient of 0.75. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)